Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;27(5):480-487.
doi: 10.1007/s11102-024-01406-y. Epub 2024 May 31.

The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency

Olivia Tausendfreund  1 , Martin Bidlingmaier  2 , Sebastian Martini  2 , Hannah Reif  2 , Michaela Rippl  2 , Katharina Schilbach  2   3 , Ralf Schmidmaier  2 , Michael Drey  2
Affiliations

The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency

Olivia Tausendfreund et al. Pituitary. 2024 Oct.

Abstract

Purpose: It is unclear whether the age-related decline in the somatotropic axis stems from a reduced growth hormone (GH) production in the pituitary gland, or from a peripheral origin akin to an acquired GH resistance. With the help of a GHRH/arginine test, high-aged multimorbid hospitalized patients with IGF-I deficiency are to be tested to determine whether there is primarily a pituitary GH deficiency in the sense of a somatopause.

Methods: Seventeen multimorbid patients (eleven men and six women) with a mean age of 82 years, with IGF-I concentrations below two standard deviations of 30-year-old men and women were identified. Patients suffered from a variety of common age-related stable diseases including coronary artery disease, chronic liver or kidney disease, chronic heart failure as well as acute conditions e.g., urosepsis or endocarditis. To assess the somatotropic axis they underwent a GHRH/arginine test. Results were evaluated using descriptive statistics.

Results: In average, the peak concentration of GH after stimulation was 14.8 µg/L with a range from 2.76 to 47.4 µg/L. Taking into account both, gender and BMI (with a mean of 26.5 kg/m²) for each participant, the pituitary gland was adequately stimulated in 16 out of the 17 patients. No patient reported common side effects related to the GHRH/arginine test.

Conclusion: The somatotroph pituitary gland retains its secretory capacity in the advanced aged. Therefore, age does not seem to be the driving pacemaker for the functional decline of the somatotropic axis within the aged population.

Keywords: Aging; GH; IGF-I; Pituitary gland; Somatopause; Somatotropic axis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Similar articles

See all similar articles

References

    1. Hage C, Salvatori R (2023) Growth hormone and aging. Endocrinol Metab Clin North Am 52:245–257. 10.1016/j.ecl.2022.10.003 - PubMed
    1. Clemmons DR (2012) Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am 41:425–443 vii–viii. 10.1016/j.ecl.2012.04.017 - PMC - PubMed
    1. Macvanin M, Gluvic Z, Radovanovic J et al (2023) New insights on the cardiovascular effects of IGF-1. Front Endocrinol (Lausanne) 14:1142644 - PMC - PubMed
    1. Isgaard J, Aberg D, Nilsson M (2007) Protective and regenerative effects of the GH/IGF-I axis on the brain. Minerva Endocrinol 32:103–113 - PubMed
    1. Jarmusch S, Baber L, Bidlingmaier M et al (2021) Influence of IGF-I serum concentration on muscular regeneration capacity in patients with Sarcopenia. BMC Musculoskelet Disord 22:807. 10.1186/s12891-021-04699-3 - PMC - PubMed

Substances

LinkOut - more resources